Stēto is a healthcare startup with a mission to create continuous care in diabetes. With a focus on Remote Patient Monitoring solutions, Stēto is addressing the global challenge of diabetes, which is projected to affect 800 million people worldwide by 2045. The healthcare industry is in need of innovative care organizations that can provide support beyond traditional periodic appointments, and Stēto aims to meet this demand. The company, founded in 2022 and based in France, is driven by a team of passionate healthcare professionals and technical experts who are dedicated to transforming the treatment of diabetes. Stēto recently secured a €1.20MSeed Round investment on 10 November 2023, with Bpifrance as the investor. Stēto's commitment to leveraging digital tools to enable daily medical support for every patient positions it as a promising player in the Health Care and Health and Wellness industries. Join Stēto on their journey to make a meaningful impact in the healthcare sector.
No recent news or press coverage available for Stēto.